Pharmacological inhibition of Bax-induced cell death: Bax-inhibiting peptides and small compounds inhibiting Bax
- Exp Biol Med (Maywood). 2019 May;244(8):621-629. doi: 10.1177/1535370219833624.
- 1. Division of Hematology and Oncology, Department of Medicine, School of Medicine, Case Western Reserve University, Case Comprehensive Cancer Center, Cleveland, OH 44106, USA.
Bax induces mitochondria-dependent programed cell death. While cytotoxic drugs activating Bax have been developed for Cancer treatment, clinically effective therapeutics suppressing Bax-induced cell death rescuing essential cells have not been developed. This mini-review will summarize previously reported Bax inhibitors including peptides, small compounds, and antibodies. We will discuss potential applications and the future direction of these Bax inhibitors.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Bcl-2 FamilyResearch Areas: Neurological Disease